Results 161 to 170 of about 123,589 (210)
Genetics of IgA Vasculitis: What We Know and Where We Are Going. [PDF]
Acta Med AcadRoganović J, Vidović A.
europepmc +1 more source
IgA Vasculitis With Nephritis Following Controlled Ovarian Stimulation and Oocyte Donation. [PDF]
CureusBrader J, Ramphul R.
europepmc +1 more source
Exploring the molecular mechanism of Qingzao Decoction in the treatment of IgA vasculitis through network pharmacology and molecular docking. [PDF]
Medicine (Baltimore)Shi Y, Ao Y, Zheng D, Liu C, Li H.
europepmc +1 more source
Efficacy and safety of traditional Chinese medicine in treating pediatric IgA vasculitis nephritis: A systematic review and meta-analysis of randomized controlled trials. [PDF]
Medicine (Baltimore)Gou Y, Huang W, Liang M.
europepmc +1 more source
IgA Vasculitis: Etiology, Treatment, Biomarkers and Epigenetic Changes
International Journal of Molecular Sciences, 2021 IgA, previously called Henoch-Schönlein vasculitis, is an essential immune component that drives the host immune response to the external environment.
Yu Sawada, Hitomi Sugino
exaly +2 more sources
Seminars in Immunopathology, 2021 IgA vasculitis (IgAV) is an inflammation of small vessels caused by perivascular deposition of IgA and activation of neutrophils. It may present as systemic vasculitis (IgAV - Henoch-Schönlein purpura) or as a variant restricted to the skin (skin-limited IgAV), while IgA nephropathy presents a variant restricted to the kidneys.
Évangéline Pillebout +1 more
exaly +4 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Current Opinion in Pediatrics, 2022
Purpose of review The purpose of this update is to summarize current knowledge on the pathophysiology of immunglobulin A (IgA) vasculitis nephritis (IgAVN) as well as to critically review evidence for established therapeutic regimes and available biomarkers. An additional purpose is to raise the discussion what could be done to
Eva, Nüsken, Lutz T, Weber
openaire +2 more sources
Purpose of review The purpose of this update is to summarize current knowledge on the pathophysiology of immunglobulin A (IgA) vasculitis nephritis (IgAVN) as well as to critically review evidence for established therapeutic regimes and available biomarkers. An additional purpose is to raise the discussion what could be done to
Eva, Nüsken, Lutz T, Weber
openaire +2 more sources
Geospatial clustering of childhood IgA vasculitis and IgA vasculitis-associated nephritis
Annals of the Rheumatic Diseases, 2021Research on spatial variability of the incidence of IgA vasculitis (IgAV) in children and its potential implications for elucidation of the multifactorial aetiology and pathogenesis is limited. We intended to observe spatial variability of the incidence of IgAV and IgA vasculitis-associated nephritis (IgAVN) using modern geostatistical methods, and ...
Matej Sapina +10 more
openaire +3 more sources
Management of IgA Vasculitis with Nephritis
Pediatric Drugs, 2021Immunoglobulin A (IgA) vasculitis (IgAV), previously called Henoch-Schönlein purpura, is characterized by IgA-dominant immune deposits affecting small vessels and often involves the skin, gastrointestinal tract, joints, and kidneys. IgAV is the most common cause of systemic vasculitis in children.
Jean-Daniel, Delbet +4 more
openaire +2 more sources